Cargando…
Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis
BACKGROUND: Multiple lines of evidence suggest possible impairment of the glymphatic system in amyotrophic lateral sclerosis (ALS). To investigate this, we used in vivo magnetic resonance imaging (MRI) to assess glymphatic function early in the course of disease in a transgenic mouse with doxycyclin...
Autores principales: | Zamani, Akram, Walker, Adam K., Rollo, Ben, Ayers, Katie L., Farah, Raysha, O’Brien, Terence J., Wright, David K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922788/ https://www.ncbi.nlm.nih.gov/pubmed/35287738 http://dx.doi.org/10.1186/s40035-022-00291-4 |
Ejemplares similares
-
Early and progressive dysfunction revealed by in vivo neurite imaging in the rNLS8 TDP-43 mouse model of ALS
por: Zamani, Akram, et al.
Publicado: (2022) -
TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014) -
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020) -
TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017) -
Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017)